Search

Author/Creator Pangan, Aileen L.

1. A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy. Issue 12 (December 2016)

Authors:
Kremer, Joel M.; Emery, Paul; Camp, Heidi S.; Friedman, Alan; Wang, Li; Othman, Ahmed A.; Khan, Nasser; Pangan, Aileen L.; Jungerwirth, Steven; Keystone, Edward C.
Journal:
Arthritis & rheumatology
Issue:
Volume 68:Issue 12(2016)
Page Start:
2867
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis. Issue 11 (November 2015)

Authors:
Burgos‐Vargas, Rubén; Tse, Shirley M. L.; Horneff, Gerd; Pangan, Aileen L.; Kalabic, Jasmina; Goss, Sandra; Unnebrink, Kristina; Anderson, Jaclyn K.
Journal:
Arthritis care & research
Issue:
Volume 67:Issue 11(2015:Nov.)
Page Start:
1503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Issue 12 (December 2016)

Authors:
Genovese, Mark C.; Smolen, Josef S.; Weinblatt, Michael E.; Burmester, Gerd R.; Meerwein, Sebastian; Camp, Heidi S.; Wang, Li; Othman, Ahmed A.; Khan, Nasser; Pangan, Aileen L.; Jungerwirth, Steven
Journal:
Arthritis & rheumatology
Issue:
Volume 68:Issue 12(2016)
Page Start:
2857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial. Issue 10 (8th September 2020)

Authors:
van Vollenhoven, Ronald; Takeuchi, Tsutomu; Pangan, Aileen L.; Friedman, Alan; Mohamed, Mohamed‐Eslam F.; Chen, Su; Rischmueller, Maureen; Blanco, Ricardo; Xavier, Ricardo M.; Strand, Vibeke
Journal:
Arthritis & rheumatology
Issue:
Volume 72:Issue 10(2020)
Page Start:
1607
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Exposure–Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit–Risk Assessment in Rheumatoid Arthritis. Issue 4 (30th November 2019)

Authors:
Nader, Ahmed; Mohamed, Mohamed‐Eslam F.; Winzenborg, Insa; Doelger, Eva; Noertersheuser, Peter; Pangan, Aileen L.; Othman, Ahmed A.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 107:Issue 4(2020)
Page Start:
994
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab. Issue 2 (29th December 2021)

Authors:
Coates, Laura C.; Abraham, Sonya; Tillett, William; Mease, Philip J.; Ramiro, Sofia; Wu, Tianshuang; Wang, Xin; Pangan, Aileen L.; Song, In‐Ho
Journal:
Arthritis care & research
Issue:
Volume 74:Issue 2(2022)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗